Number (%) | ||||
---|---|---|---|---|
Cardiology | Mental health | Oncology | Total | |
Total number of studies | 20 (38.5) | 17 (32.7) | 15 (28.8) | 52 (100) |
Geography | ||||
USA | 8a (40.0) | 10 (58.8) | 5 (33.3) | 23 (44.2) |
The Netherlands | 1 (5.0) | 3 (17.6) | 2 (13.3) | 6 (11.5) |
Germany | 1 (5.0) | 2 (11.8) | 2 (13.3) | 5 (9.6) |
Canada | 3 (15.0) | 1 (5.9) | 1 (6.7) | 5 (9.6) |
Other | 7 (35.0) | 1 (5.9) | 5 (33.3) | 13 (25.0) |
Methodb | ||||
A only | 9 (45.0) | 2 (11.8) | 7 (46.7) | 18 (34.6) |
B only | 9 (45.0) | 12 (70.6) | 6 (40.0) | 27 (51.9) |
A and B | 2 (10.0) | 3 (17.6) | 2 (13.3) | 7 (13.5) |
Comparisons made, Method Ac,d | ||||
Demographics | 10 (90.9) | 5 (100) | 8 (88.9) | 23 (92.0) |
Clinical characteristics | 8 (72.7) | 5 (100) | 7 (77.8) | 20 (80.0) |
Treatments and procedures | 4 (36.4) | 2 (40.0) | 3 (33.3) | 9 (36.0) |
Othere | 1 (9.1) | 1 (20.0) | 0 (0.0) | 2 (8.0) |
Additional analyses undertaken, Method Bd | ||||
Comparison of baseline characteristics, eligible vs ineligible patients | 6 (54.5) | 6 (40.0) | 1 (12.5) | 13 (38.2) |
Common reasons for trial ineligibility | 7 (63.6) | 14 (93.3) | 8 (100) | 29 (85.3) |